• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Merck & Co (NY:MRK)

    110.27 +1.93 (+1.78%)
    Official Closing Price Updated: 6:30 PM EST, Jan 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 19,060,093
    Open 108.59
    Bid (Size) 110.26 (200)
    Ask (Size) 110.50 (100)
    Prev. Close 108.34
    Today's Range 107.95 - 110.53
    52wk Range 73.31 - 112.90
    Shares Outstanding 2,531,374,696
    Dividend Yield 3.08%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Should You Buy Guardant Health Before Feb. 19? ↗
    This genomics stock appears to be at an inflection point. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    2 Cash-Producing Stocks to Target This Week and 1 We Ignore
    While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
    Via StockStory

    Performance

    YTD
    +3.6%
    +3.6%
    1 Month
    +4.0%
    +4.0%
    3 Month
    +27.8%
    +27.8%
    6 Month
    +41.2%
    +41.2%
    1 Year
    +12.2%
    +12.2%

    More News

    Read More
    News headline image
    This Stock Is Already Up 58% This Year. Is It a Buy? ↗
    Via The Motley Fool
    News headline image
    Constitutional Cliffhanger: Supreme Court Set to Rule on Executive Tariff Power as Market Braces for Margin Volatility
    Via MarketMinute
    Topics Economy Government World Trade
    Merck & Co. Inc. (NYSE:MRK) Stands Out as a High-Quality Dividend Stock ↗
    Via Chartmill
    News headline image
    The $4 Billion Avatar: How Synthesia is Defining the Era of Agentic Enterprise Media
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    FDA Codifies AI’s Role in Drug Production: New 2026 Guidelines Set Global Standard for Pharma Safety and Efficiency
    Via TokenRing AI
    Topics Artificial Intelligence Economy
    News headline image
    Merck Announces Second-Quarter 2026 Dividend
    From Merck & Co., Inc.
    Via Business Wire
    News headline image
    2 Pharmaceutical Stocks Set to Rebound in 2026 ↗
    Via The Motley Fool
    News headline image
    Why Revolution Medicines Stock Plummeted by Almost 17% Today ↗
    Via The Motley Fool
    News headline image
    The Post-Keytruda Pivot: Inside Merck’s Strategic Evolution and the RVMD Landscape
    Via Finterra
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
    Via Finterra
    Topics Economy Initial Public Offering
    News headline image
    Revolution Medicines Stock Sinks After Merck Deal Talks Collapse ↗
    Via Benzinga
    Nasdaq, S&P 500 Futures Open The Week On Edge As Earnings, Tariffs, Fed Decision Loom: Why META, NVDA, RVMD, USAR Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Economy Stocks
    News headline image
    Revolution Medicines Stock Stares At Big Dip After Merck Reportedly Shelves Buyout — But Analyst Flags Opportunity ↗
    Via Stocktwits
    News headline image
    2 Under-the-Radar Biotech Stocks Set to Boom in 2026 ↗
    Via The Motley Fool
    Topics ETFs Intellectual Property World Trade
    News headline image
    2 Dirt Cheap Stocks to Buy With $200 Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? ↗
    Via The Motley Fool
    News headline image
    2 Soaring Stocks to Hold for the Next 20 Years ↗
    Via The Motley Fool
    Topics Intellectual Property World Trade
    News headline image
    Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
    Via MarketMinute
    Topics Artificial Intelligence Bankruptcy Economy
    News headline image
    I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026. ↗
    Via The Motley Fool
    Topics Stocks
    News headline image
    Moderna and Merck Solidify Oncology Leadership as Five-Year Melanoma Data Fuels Market Rally
    Via MarketMinute
    Topics Intellectual Property
    News headline image
    Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth
    Via MarketMinute
    Topics Earnings Economy Intellectual Property
    News headline image
    Moderna’s 2026 Pivot: From Pandemic Pioneer to Oncology Powerhouse
    Via Finterra
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm
    Via StockStory
    Topics Economy Stocks

    Frequently Asked Questions

    Is Merck & Co publicly traded?
    Yes, Merck & Co is publicly traded.
    What exchange does Merck & Co trade on?
    Merck & Co trades on the New York Stock Exchange
    What is the ticker symbol for Merck & Co?
    The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
    What is the current price of Merck & Co?
    The current price of Merck & Co is 110.27
    When was Merck & Co last traded?
    The last trade of Merck & Co was at 01/30/26 06:30 PM ET
    What is the market capitalization of Merck & Co?
    The market capitalization of Merck & Co is 279.13B
    How many shares of Merck & Co are outstanding?
    Merck & Co has 279B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.